BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 12030011)

  • 1. [Functional significance of MeCP2 mutations in patients with Rett syndrome].
    Kudo S
    No To Hattatsu; 2002 May; 34(3):224-9. PubMed ID: 12030011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analyses of MeCP2 mutations associated with Rett syndrome using transient expression systems.
    Kudo S; Nomura Y; Segawa M; Fujita N; Nakao M; Dragich J; Schanen C; Tamura M
    Brain Dev; 2001 Dec; 23 Suppl 1():S165-73. PubMed ID: 11738866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome.
    Buschdorf JP; Strätling WH
    J Mol Med (Berl); 2004 Feb; 82(2):135-43. PubMed ID: 14618241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rett syndrome: a surprising result of mutation in MECP2.
    Dragich J; Houwink-Manville I; Schanen C
    Hum Mol Genet; 2000 Oct; 9(16):2365-75. PubMed ID: 11005791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of the MECP2 gene in Japanese patients with Rett syndrome.
    Amano K; Nomura Y; Segawa M; Yamakawa K
    J Hum Genet; 2000; 45(4):231-6. PubMed ID: 10944854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype.
    Hoffbuhr KC; Moses LM; Jerdonek MA; Naidu S; Hoffman EP
    Ment Retard Dev Disabil Res Rev; 2002; 8(2):99-105. PubMed ID: 12112735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain.
    Kudo S; Nomura Y; Segawa M; Fujita N; Nakao M; Schanen C; Tamura M
    J Med Genet; 2003 Jul; 40(7):487-93. PubMed ID: 12843318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry.
    LaSalle JM; Goldstine J; Balmer D; Greco CM
    Hum Mol Genet; 2001 Aug; 10(17):1729-40. PubMed ID: 11532982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for mutations in the MECP2 (Rett syndrome) gene in Gilles de la Tourette syndrome.
    Rosa AL; Jankovic J; Ashizawa T
    Arch Neurol; 2003 Apr; 60(4):502-3. PubMed ID: 12707062
    [No Abstract]   [Full Text] [Related]  

  • 10. Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations.
    Amir RE; Zoghbi HY
    Am J Med Genet; 2000; 97(2):147-52. PubMed ID: 11180222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA.
    Ballestar E; Yusufzai TM; Wolffe AP
    Biochemistry; 2000 Jun; 39(24):7100-6. PubMed ID: 10852707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the gene encoding methyl-CpG-binding protein 2 cause Rett syndrome.
    Van den Veyver IB; Zoghbi HY
    Brain Dev; 2001 Dec; 23 Suppl 1():S147-51. PubMed ID: 11738862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations.
    Shahbazian MD; Zoghbi HY
    Curr Opin Neurol; 2001 Apr; 14(2):171-6. PubMed ID: 11262731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in exon 1 coding region and promoter of MECP2 in Rett syndrome and controls.
    Evans JC; Archer HL; Whatley SD; Kerr A; Clarke A; Butler R
    Eur J Hum Genet; 2005 Jan; 13(1):124-6. PubMed ID: 15367913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methyl-CpG-binding protein 2 mutations in Rett syndrome.
    Van den Veyver IB; Zoghbi HY
    Curr Opin Genet Dev; 2000 Jun; 10(3):275-9. PubMed ID: 10826991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis of MECP2 and clinical characterization in Korean patients with Rett syndrome.
    Chae JH; Hwang YS; Kim KJ
    J Child Neurol; 2002 Jan; 17(1):33-6. PubMed ID: 11913567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Another patient with MECP2 mutation without classic Rett syndrome phenotype.
    Milani D; Pantaleoni C; D'Arrigo S; Selicorni A; Riva D
    Pediatr Neurol; 2005 May; 32(5):355-7. PubMed ID: 15866439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis in Rett syndrome.
    Milunsky JM; Lebo RV; Ikuta T; Maher TA; Haverty CE; Milunsky A
    Genet Test; 2001; 5(4):321-5. PubMed ID: 11960578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rett syndrome: a prototypical neurodevelopmental disorder.
    Neul JL; Zoghbi HY
    Neuroscientist; 2004 Apr; 10(2):118-28. PubMed ID: 15070486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MECP2 and beyond: phenotype-genotype correlations in Rett syndrome.
    Christodoulou J; Weaving LS
    J Child Neurol; 2003 Oct; 18(10):669-74. PubMed ID: 14649547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.